nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ESR1—coronary artery disease	0.289	1	CbGaD
Toremifene—ABCB1—Ticagrelor—coronary artery disease	0.0346	0.0734	CbGbCtD
Toremifene—CYP1A2—Gemfibrozil—coronary artery disease	0.0282	0.0598	CbGbCtD
Toremifene—CYP1A2—Clopidogrel—coronary artery disease	0.0244	0.0519	CbGbCtD
Toremifene—ABCB1—Perindopril—coronary artery disease	0.0213	0.0453	CbGbCtD
Toremifene—ABCB1—Clopidogrel—coronary artery disease	0.0213	0.0453	CbGbCtD
Toremifene—CYP3A4—Ticagrelor—coronary artery disease	0.0207	0.044	CbGbCtD
Toremifene—ABCB1—Telmisartan—coronary artery disease	0.0187	0.0396	CbGbCtD
Toremifene—ABCB1—Pitavastatin—coronary artery disease	0.0187	0.0396	CbGbCtD
Toremifene—CYP3A4—Fenofibrate—coronary artery disease	0.0185	0.0392	CbGbCtD
Toremifene—ABCB1—Lisinopril—coronary artery disease	0.0177	0.0376	CbGbCtD
Toremifene—ABCB1—Enalapril—coronary artery disease	0.0177	0.0376	CbGbCtD
Toremifene—ABCB1—Timolol—coronary artery disease	0.015	0.0319	CbGbCtD
Toremifene—CYP3A4—Gemfibrozil—coronary artery disease	0.0148	0.0313	CbGbCtD
Toremifene—ABCB1—Ezetimibe—coronary artery disease	0.0138	0.0292	CbGbCtD
Toremifene—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0134	0.0285	CbGbCtD
Toremifene—ABCB1—Captopril—coronary artery disease	0.0132	0.0281	CbGbCtD
Toremifene—CYP3A4—Clopidogrel—coronary artery disease	0.0128	0.0272	CbGbCtD
Toremifene—ABCB1—Simvastatin—coronary artery disease	0.0128	0.0272	CbGbCtD
Toremifene—ABCB1—Pravastatin—coronary artery disease	0.0125	0.0266	CbGbCtD
Toremifene—ABCB1—Lovastatin—coronary artery disease	0.0125	0.0266	CbGbCtD
Toremifene—CYP1A2—Losartan—coronary artery disease	0.0119	0.0253	CbGbCtD
Toremifene—CYP3A4—Eplerenone—coronary artery disease	0.0119	0.0253	CbGbCtD
Toremifene—ABCB1—Atorvastatin—coronary artery disease	0.0114	0.0242	CbGbCtD
Toremifene—CYP3A4—Enalapril—coronary artery disease	0.0106	0.0225	CbGbCtD
Toremifene—ABCB1—Losartan—coronary artery disease	0.0104	0.0221	CbGbCtD
Toremifene—CYP3A4—Ezetimibe—coronary artery disease	0.00824	0.0175	CbGbCtD
Toremifene—CYP3A4—Rosuvastatin—coronary artery disease	0.00824	0.0175	CbGbCtD
Toremifene—CYP3A4—Simvastatin—coronary artery disease	0.00766	0.0163	CbGbCtD
Toremifene—CYP3A4—Lovastatin—coronary artery disease	0.0075	0.0159	CbGbCtD
Toremifene—CYP3A4—Pravastatin—coronary artery disease	0.0075	0.0159	CbGbCtD
Toremifene—CYP3A4—Atorvastatin—coronary artery disease	0.00683	0.0145	CbGbCtD
Toremifene—CYP3A4—Losartan—coronary artery disease	0.00625	0.0133	CbGbCtD
Toremifene—Tamoxifen—SULT1A1—coronary artery disease	0.000562	0.18	CrCbGaD
Toremifene—Loperamide—POMC—coronary artery disease	0.000483	0.155	CrCbGaD
Toremifene—Ospemifene—ESR1—coronary artery disease	0.000299	0.0958	CrCbGaD
Toremifene—Dextropropoxyphene—OPRD1—coronary artery disease	0.000286	0.0916	CrCbGaD
Toremifene—Loperamide—OPRD1—coronary artery disease	0.000272	0.0872	CrCbGaD
Toremifene—Phenoxybenzamine—SLC22A3—coronary artery disease	0.000243	0.0779	CrCbGaD
Toremifene—Ospemifene—CYP2C19—coronary artery disease	0.00024	0.0769	CrCbGaD
Toremifene—Clomifene—ESR1—coronary artery disease	0.000211	0.0675	CrCbGaD
Toremifene—Tamoxifen—ESR2—coronary artery disease	0.000158	0.0506	CrCbGaD
Toremifene—Fatigue—Trandolapril—coronary artery disease	0.000119	0.000717	CcSEcCtD
Toremifene—Pruritus—Lovastatin—coronary artery disease	0.000119	0.000716	CcSEcCtD
Toremifene—Anorexia—Furosemide—coronary artery disease	0.000118	0.000715	CcSEcCtD
Toremifene—Fatigue—Enalapril—coronary artery disease	0.000118	0.000714	CcSEcCtD
Toremifene—Mediastinal disorder—Lisinopril—coronary artery disease	0.000118	0.000714	CcSEcCtD
Toremifene—Asthenia—Ezetimibe—coronary artery disease	0.000118	0.000713	CcSEcCtD
Toremifene—Tremor—Ramipril—coronary artery disease	0.000118	0.000712	CcSEcCtD
Toremifene—Constipation—Trandolapril—coronary artery disease	0.000118	0.000711	CcSEcCtD
Toremifene—Chills—Lisinopril—coronary artery disease	0.000118	0.000711	CcSEcCtD
Toremifene—Decreased appetite—Telmisartan—coronary artery disease	0.000118	0.00071	CcSEcCtD
Toremifene—Nausea—Rosuvastatin—coronary artery disease	0.000118	0.00071	CcSEcCtD
Toremifene—Nervous system disorder—Losartan—coronary artery disease	0.000118	0.000709	CcSEcCtD
Toremifene—Thrombocytopenia—Losartan—coronary artery disease	0.000117	0.000708	CcSEcCtD
Toremifene—Constipation—Enalapril—coronary artery disease	0.000117	0.000708	CcSEcCtD
Toremifene—Dyspnoea—Captopril—coronary artery disease	0.000117	0.000708	CcSEcCtD
Toremifene—Arrhythmia—Lisinopril—coronary artery disease	0.000117	0.000707	CcSEcCtD
Toremifene—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000117	0.000705	CcSEcCtD
Toremifene—Fatigue—Telmisartan—coronary artery disease	0.000117	0.000704	CcSEcCtD
Toremifene—Pruritus—Ezetimibe—coronary artery disease	0.000116	0.000703	CcSEcCtD
Toremifene—Vision blurred—Timolol—coronary artery disease	0.000116	0.0007	CcSEcCtD
Toremifene—Alopecia—Lisinopril—coronary artery disease	0.000116	0.0007	CcSEcCtD
Toremifene—Hyperhidrosis—Losartan—coronary artery disease	0.000116	0.000699	CcSEcCtD
Toremifene—Pain—Telmisartan—coronary artery disease	0.000116	0.000699	CcSEcCtD
Toremifene—Constipation—Telmisartan—coronary artery disease	0.000116	0.000699	CcSEcCtD
Toremifene—Insomnia—Perindopril—coronary artery disease	0.000116	0.000698	CcSEcCtD
Toremifene—Asthenia—Eplerenone—coronary artery disease	0.000116	0.000698	CcSEcCtD
Toremifene—Mental disorder—Lisinopril—coronary artery disease	0.000115	0.000694	CcSEcCtD
Toremifene—Decreased appetite—Captopril—coronary artery disease	0.000114	0.000691	CcSEcCtD
Toremifene—Anorexia—Losartan—coronary artery disease	0.000114	0.00069	CcSEcCtD
Toremifene—Nausea—Acetylsalicylic acid—coronary artery disease	0.000114	0.00069	CcSEcCtD
Toremifene—Malnutrition—Lisinopril—coronary artery disease	0.000114	0.000689	CcSEcCtD
Toremifene—Pruritus—Eplerenone—coronary artery disease	0.000114	0.000688	CcSEcCtD
Toremifene—Dyspnoea—Perindopril—coronary artery disease	0.000114	0.000688	CcSEcCtD
Toremifene—Dizziness—Fenofibrate—coronary artery disease	0.000114	0.000686	CcSEcCtD
Toremifene—Fatigue—Captopril—coronary artery disease	0.000113	0.000685	CcSEcCtD
Toremifene—Vertigo—Ramipril—coronary artery disease	0.000113	0.000683	CcSEcCtD
Toremifene—Leukopenia—Ramipril—coronary artery disease	0.000113	0.00068	CcSEcCtD
Toremifene—Asthenia—Simvastatin—coronary artery disease	0.000113	0.00068	CcSEcCtD
Toremifene—Constipation—Captopril—coronary artery disease	0.000113	0.000679	CcSEcCtD
Toremifene—Dizziness—Clopidogrel—coronary artery disease	0.000112	0.000674	CcSEcCtD
Toremifene—Phenoxybenzamine—ADRB2—coronary artery disease	0.000111	0.0356	CrCbGaD
Toremifene—Decreased appetite—Perindopril—coronary artery disease	0.000111	0.00067	CcSEcCtD
Toremifene—Pruritus—Simvastatin—coronary artery disease	0.000111	0.00067	CcSEcCtD
Toremifene—Dizziness—Lovastatin—coronary artery disease	0.000111	0.00067	CcSEcCtD
Toremifene—Vertigo—Timolol—coronary artery disease	0.000111	0.000668	CcSEcCtD
Toremifene—Back pain—Lisinopril—coronary artery disease	0.00011	0.000667	CcSEcCtD
Toremifene—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00011	0.000666	CcSEcCtD
Toremifene—Fatigue—Perindopril—coronary artery disease	0.00011	0.000665	CcSEcCtD
Toremifene—Constipation—Perindopril—coronary artery disease	0.000109	0.00066	CcSEcCtD
Toremifene—Pain—Perindopril—coronary artery disease	0.000109	0.00066	CcSEcCtD
Toremifene—Vomiting—Fenofibrate—coronary artery disease	0.000109	0.000659	CcSEcCtD
Toremifene—Dizziness—Ezetimibe—coronary artery disease	0.000109	0.000657	CcSEcCtD
Toremifene—Insomnia—Losartan—coronary artery disease	0.000108	0.000654	CcSEcCtD
Toremifene—Rash—Fenofibrate—coronary artery disease	0.000108	0.000654	CcSEcCtD
Toremifene—Dermatitis—Fenofibrate—coronary artery disease	0.000108	0.000653	CcSEcCtD
Toremifene—Decreased appetite—Furosemide—coronary artery disease	0.000108	0.000652	CcSEcCtD
Toremifene—Headache—Fenofibrate—coronary artery disease	0.000108	0.00065	CcSEcCtD
Toremifene—Vision blurred—Lisinopril—coronary artery disease	0.000108	0.00065	CcSEcCtD
Toremifene—Vomiting—Clopidogrel—coronary artery disease	0.000107	0.000648	CcSEcCtD
Toremifene—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000107	0.000647	CcSEcCtD
Toremifene—Chest pain—Ramipril—coronary artery disease	0.000107	0.000647	CcSEcCtD
Toremifene—Fatigue—Furosemide—coronary artery disease	0.000107	0.000646	CcSEcCtD
Toremifene—Tremor—Lisinopril—coronary artery disease	0.000107	0.000646	CcSEcCtD
Toremifene—Dyspnoea—Losartan—coronary artery disease	0.000107	0.000645	CcSEcCtD
Toremifene—Vomiting—Lovastatin—coronary artery disease	0.000107	0.000644	CcSEcCtD
Toremifene—Dizziness—Eplerenone—coronary artery disease	0.000106	0.000643	CcSEcCtD
Toremifene—Rash—Clopidogrel—coronary artery disease	0.000106	0.000643	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000106	0.000643	CcSEcCtD
Toremifene—Dermatitis—Clopidogrel—coronary artery disease	0.000106	0.000642	CcSEcCtD
Toremifene—Asthenia—Valsartan—coronary artery disease	0.000106	0.000642	CcSEcCtD
Toremifene—Constipation—Furosemide—coronary artery disease	0.000106	0.000641	CcSEcCtD
Toremifene—Pain—Furosemide—coronary artery disease	0.000106	0.000641	CcSEcCtD
Toremifene—Asthenia—Olmesartan—coronary artery disease	0.000106	0.000639	CcSEcCtD
Toremifene—Headache—Clopidogrel—coronary artery disease	0.000106	0.000639	CcSEcCtD
Toremifene—Rash—Lovastatin—coronary artery disease	0.000106	0.000639	CcSEcCtD
Toremifene—Dermatitis—Lovastatin—coronary artery disease	0.000106	0.000638	CcSEcCtD
Toremifene—Headache—Lovastatin—coronary artery disease	0.000105	0.000634	CcSEcCtD
Toremifene—Pruritus—Valsartan—coronary artery disease	0.000105	0.000633	CcSEcCtD
Toremifene—Chest pain—Timolol—coronary artery disease	0.000105	0.000633	CcSEcCtD
Toremifene—Vomiting—Ezetimibe—coronary artery disease	0.000105	0.000632	CcSEcCtD
Toremifene—Pruritus—Olmesartan—coronary artery disease	0.000104	0.00063	CcSEcCtD
Toremifene—Decreased appetite—Losartan—coronary artery disease	0.000104	0.000629	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000104	0.000628	CcSEcCtD
Toremifene—Dizziness—Simvastatin—coronary artery disease	0.000104	0.000626	CcSEcCtD
Toremifene—Rash—Ezetimibe—coronary artery disease	0.000104	0.000626	CcSEcCtD
Toremifene—Dermatitis—Ezetimibe—coronary artery disease	0.000104	0.000626	CcSEcCtD
Toremifene—Asthenia—Niacin—coronary artery disease	0.000103	0.000624	CcSEcCtD
Toremifene—Fatigue—Losartan—coronary artery disease	0.000103	0.000624	CcSEcCtD
Toremifene—Headache—Ezetimibe—coronary artery disease	0.000103	0.000622	CcSEcCtD
Toremifene—Oedema—Ramipril—coronary artery disease	0.000103	0.00062	CcSEcCtD
Toremifene—Vertigo—Lisinopril—coronary artery disease	0.000103	0.000619	CcSEcCtD
Toremifene—Pain—Losartan—coronary artery disease	0.000102	0.000619	CcSEcCtD
Toremifene—Constipation—Losartan—coronary artery disease	0.000102	0.000619	CcSEcCtD
Toremifene—Vomiting—Eplerenone—coronary artery disease	0.000102	0.000618	CcSEcCtD
Toremifene—Leukopenia—Lisinopril—coronary artery disease	0.000102	0.000617	CcSEcCtD
Toremifene—Nausea—Fenofibrate—coronary artery disease	0.000102	0.000616	CcSEcCtD
Toremifene—Pruritus—Niacin—coronary artery disease	0.000102	0.000615	CcSEcCtD
Toremifene—Asthenia—Pravastatin—coronary artery disease	0.000102	0.000614	CcSEcCtD
Toremifene—Rash—Eplerenone—coronary artery disease	0.000102	0.000613	CcSEcCtD
Toremifene—Dermatitis—Eplerenone—coronary artery disease	0.000101	0.000612	CcSEcCtD
Toremifene—Headache—Eplerenone—coronary artery disease	0.000101	0.000609	CcSEcCtD
Toremifene—Nervous system disorder—Ramipril—coronary artery disease	0.000101	0.000608	CcSEcCtD
Toremifene—Thrombocytopenia—Ramipril—coronary artery disease	0.000101	0.000607	CcSEcCtD
Toremifene—Oedema—Timolol—coronary artery disease	0.0001	0.000606	CcSEcCtD
Toremifene—Pruritus—Pravastatin—coronary artery disease	0.0001	0.000606	CcSEcCtD
Toremifene—Nausea—Clopidogrel—coronary artery disease	0.0001	0.000606	CcSEcCtD
Toremifene—Skin disorder—Ramipril—coronary artery disease	9.98e-05	0.000603	CcSEcCtD
Toremifene—Vomiting—Simvastatin—coronary artery disease	9.98e-05	0.000602	CcSEcCtD
Toremifene—Nausea—Lovastatin—coronary artery disease	9.96e-05	0.000602	CcSEcCtD
Toremifene—Hyperhidrosis—Ramipril—coronary artery disease	9.93e-05	0.0006	CcSEcCtD
Toremifene—Rash—Simvastatin—coronary artery disease	9.89e-05	0.000597	CcSEcCtD
Toremifene—Dermatitis—Simvastatin—coronary artery disease	9.88e-05	0.000597	CcSEcCtD
Toremifene—Asthenia—Trandolapril—coronary artery disease	9.88e-05	0.000597	CcSEcCtD
Toremifene—Nervous system disorder—Timolol—coronary artery disease	9.85e-05	0.000595	CcSEcCtD
Toremifene—Asthenia—Enalapril—coronary artery disease	9.84e-05	0.000594	CcSEcCtD
Toremifene—Headache—Simvastatin—coronary artery disease	9.83e-05	0.000593	CcSEcCtD
Toremifene—Dizziness—Valsartan—coronary artery disease	9.8e-05	0.000592	CcSEcCtD
Toremifene—Anorexia—Ramipril—coronary artery disease	9.79e-05	0.000591	CcSEcCtD
Toremifene—Nausea—Ezetimibe—coronary artery disease	9.77e-05	0.00059	CcSEcCtD
Toremifene—Skin disorder—Timolol—coronary artery disease	9.76e-05	0.000589	CcSEcCtD
Toremifene—Dizziness—Olmesartan—coronary artery disease	9.75e-05	0.000589	CcSEcCtD
Toremifene—Pruritus—Trandolapril—coronary artery disease	9.75e-05	0.000588	CcSEcCtD
Toremifene—Tamoxifen—ESR1—coronary artery disease	9.74e-05	0.0312	CrCbGaD
Toremifene—Chest pain—Lisinopril—coronary artery disease	9.72e-05	0.000587	CcSEcCtD
Toremifene—Hyperhidrosis—Timolol—coronary artery disease	9.71e-05	0.000586	CcSEcCtD
Toremifene—Asthenia—Telmisartan—coronary artery disease	9.71e-05	0.000586	CcSEcCtD
Toremifene—Pruritus—Enalapril—coronary artery disease	9.71e-05	0.000586	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	9.65e-05	0.000583	CcSEcCtD
Toremifene—Anorexia—Timolol—coronary artery disease	9.58e-05	0.000578	CcSEcCtD
Toremifene—Pruritus—Telmisartan—coronary artery disease	9.57e-05	0.000578	CcSEcCtD
Toremifene—Nausea—Eplerenone—coronary artery disease	9.56e-05	0.000577	CcSEcCtD
Toremifene—Dizziness—Niacin—coronary artery disease	9.53e-05	0.000575	CcSEcCtD
Toremifene—Asthenia—Captopril—coronary artery disease	9.44e-05	0.00057	CcSEcCtD
Toremifene—Vomiting—Valsartan—coronary artery disease	9.42e-05	0.000569	CcSEcCtD
Toremifene—Dizziness—Pravastatin—coronary artery disease	9.38e-05	0.000566	CcSEcCtD
Toremifene—Vomiting—Olmesartan—coronary artery disease	9.38e-05	0.000566	CcSEcCtD
Toremifene—Rash—Valsartan—coronary artery disease	9.34e-05	0.000564	CcSEcCtD
Toremifene—Dermatitis—Valsartan—coronary artery disease	9.33e-05	0.000563	CcSEcCtD
Toremifene—Nausea—Simvastatin—coronary artery disease	9.32e-05	0.000563	CcSEcCtD
Toremifene—Oedema—Lisinopril—coronary artery disease	9.32e-05	0.000563	CcSEcCtD
Toremifene—Pruritus—Captopril—coronary artery disease	9.31e-05	0.000562	CcSEcCtD
Toremifene—Rash—Olmesartan—coronary artery disease	9.3e-05	0.000561	CcSEcCtD
Toremifene—Insomnia—Ramipril—coronary artery disease	9.29e-05	0.000561	CcSEcCtD
Toremifene—Dermatitis—Olmesartan—coronary artery disease	9.29e-05	0.000561	CcSEcCtD
Toremifene—Headache—Valsartan—coronary artery disease	9.28e-05	0.00056	CcSEcCtD
Toremifene—Headache—Olmesartan—coronary artery disease	9.24e-05	0.000558	CcSEcCtD
Toremifene—Asthenia—Perindopril—coronary artery disease	9.17e-05	0.000553	CcSEcCtD
Toremifene—Dyspnoea—Ramipril—coronary artery disease	9.16e-05	0.000553	CcSEcCtD
Toremifene—Vomiting—Niacin—coronary artery disease	9.16e-05	0.000553	CcSEcCtD
Toremifene—Thrombocytopenia—Lisinopril—coronary artery disease	9.12e-05	0.000551	CcSEcCtD
Toremifene—Dizziness—Trandolapril—coronary artery disease	9.11e-05	0.00055	CcSEcCtD
Toremifene—Insomnia—Timolol—coronary artery disease	9.09e-05	0.000549	CcSEcCtD
Toremifene—Rash—Niacin—coronary artery disease	9.08e-05	0.000548	CcSEcCtD
Toremifene—Dermatitis—Niacin—coronary artery disease	9.08e-05	0.000548	CcSEcCtD
Toremifene—Dizziness—Enalapril—coronary artery disease	9.07e-05	0.000548	CcSEcCtD
Toremifene—Skin disorder—Lisinopril—coronary artery disease	9.05e-05	0.000546	CcSEcCtD
Toremifene—Pruritus—Perindopril—coronary artery disease	9.04e-05	0.000546	CcSEcCtD
Toremifene—Headache—Niacin—coronary artery disease	9.03e-05	0.000545	CcSEcCtD
Toremifene—Vomiting—Pravastatin—coronary artery disease	9.02e-05	0.000544	CcSEcCtD
Toremifene—Hyperhidrosis—Lisinopril—coronary artery disease	9.01e-05	0.000544	CcSEcCtD
Toremifene—Dyspnoea—Timolol—coronary artery disease	8.96e-05	0.000541	CcSEcCtD
Toremifene—Dizziness—Telmisartan—coronary artery disease	8.95e-05	0.00054	CcSEcCtD
Toremifene—Rash—Pravastatin—coronary artery disease	8.94e-05	0.00054	CcSEcCtD
Toremifene—Dermatitis—Pravastatin—coronary artery disease	8.94e-05	0.000539	CcSEcCtD
Toremifene—Decreased appetite—Ramipril—coronary artery disease	8.93e-05	0.000539	CcSEcCtD
Toremifene—Asthenia—Furosemide—coronary artery disease	8.91e-05	0.000538	CcSEcCtD
Toremifene—Headache—Pravastatin—coronary artery disease	8.89e-05	0.000536	CcSEcCtD
Toremifene—Anorexia—Lisinopril—coronary artery disease	8.88e-05	0.000536	CcSEcCtD
Toremifene—Gastrointestinal disorder—Ramipril—coronary artery disease	8.87e-05	0.000536	CcSEcCtD
Toremifene—Fatigue—Ramipril—coronary artery disease	8.86e-05	0.000535	CcSEcCtD
Toremifene—Nausea—Valsartan—coronary artery disease	8.8e-05	0.000531	CcSEcCtD
Toremifene—Pruritus—Furosemide—coronary artery disease	8.79e-05	0.00053	CcSEcCtD
Toremifene—Constipation—Ramipril—coronary artery disease	8.79e-05	0.00053	CcSEcCtD
Toremifene—Nausea—Olmesartan—coronary artery disease	8.76e-05	0.000529	CcSEcCtD
Toremifene—Vomiting—Trandolapril—coronary artery disease	8.76e-05	0.000529	CcSEcCtD
Toremifene—Decreased appetite—Timolol—coronary artery disease	8.73e-05	0.000527	CcSEcCtD
Toremifene—Vomiting—Enalapril—coronary artery disease	8.72e-05	0.000527	CcSEcCtD
Toremifene—Dizziness—Captopril—coronary artery disease	8.7e-05	0.000525	CcSEcCtD
Toremifene—Rash—Trandolapril—coronary artery disease	8.69e-05	0.000524	CcSEcCtD
Toremifene—Dermatitis—Trandolapril—coronary artery disease	8.68e-05	0.000524	CcSEcCtD
Toremifene—Gastrointestinal disorder—Timolol—coronary artery disease	8.67e-05	0.000524	CcSEcCtD
Toremifene—Fatigue—Timolol—coronary artery disease	8.66e-05	0.000523	CcSEcCtD
Toremifene—Rash—Enalapril—coronary artery disease	8.65e-05	0.000522	CcSEcCtD
Toremifene—Dermatitis—Enalapril—coronary artery disease	8.64e-05	0.000522	CcSEcCtD
Toremifene—Headache—Trandolapril—coronary artery disease	8.63e-05	0.000521	CcSEcCtD
Toremifene—Vomiting—Telmisartan—coronary artery disease	8.6e-05	0.000519	CcSEcCtD
Toremifene—Asthenia—Losartan—coronary artery disease	8.6e-05	0.000519	CcSEcCtD
Toremifene—Headache—Enalapril—coronary artery disease	8.59e-05	0.000519	CcSEcCtD
Toremifene—Pain—Timolol—coronary artery disease	8.59e-05	0.000519	CcSEcCtD
Toremifene—Nausea—Niacin—coronary artery disease	8.56e-05	0.000517	CcSEcCtD
Toremifene—Rash—Telmisartan—coronary artery disease	8.53e-05	0.000515	CcSEcCtD
Toremifene—Dermatitis—Telmisartan—coronary artery disease	8.52e-05	0.000515	CcSEcCtD
Toremifene—Pruritus—Losartan—coronary artery disease	8.48e-05	0.000512	CcSEcCtD
Toremifene—Headache—Telmisartan—coronary artery disease	8.48e-05	0.000512	CcSEcCtD
Toremifene—Dizziness—Perindopril—coronary artery disease	8.45e-05	0.00051	CcSEcCtD
Toremifene—Insomnia—Lisinopril—coronary artery disease	8.43e-05	0.000509	CcSEcCtD
Toremifene—Nausea—Pravastatin—coronary artery disease	8.43e-05	0.000509	CcSEcCtD
Toremifene—Vomiting—Captopril—coronary artery disease	8.37e-05	0.000505	CcSEcCtD
Toremifene—Dyspnoea—Lisinopril—coronary artery disease	8.31e-05	0.000502	CcSEcCtD
Toremifene—Rash—Captopril—coronary artery disease	8.3e-05	0.000501	CcSEcCtD
Toremifene—Dermatitis—Captopril—coronary artery disease	8.29e-05	0.0005	CcSEcCtD
Toremifene—Headache—Captopril—coronary artery disease	8.24e-05	0.000498	CcSEcCtD
Toremifene—Dizziness—Furosemide—coronary artery disease	8.21e-05	0.000496	CcSEcCtD
Toremifene—Nausea—Trandolapril—coronary artery disease	8.18e-05	0.000494	CcSEcCtD
Toremifene—Nausea—Enalapril—coronary artery disease	8.15e-05	0.000492	CcSEcCtD
Toremifene—Vomiting—Perindopril—coronary artery disease	8.12e-05	0.00049	CcSEcCtD
Toremifene—Decreased appetite—Lisinopril—coronary artery disease	8.1e-05	0.000489	CcSEcCtD
Toremifene—Rash—Perindopril—coronary artery disease	8.06e-05	0.000486	CcSEcCtD
Toremifene—Dermatitis—Perindopril—coronary artery disease	8.05e-05	0.000486	CcSEcCtD
Toremifene—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.05e-05	0.000486	CcSEcCtD
Toremifene—Nausea—Telmisartan—coronary artery disease	8.04e-05	0.000485	CcSEcCtD
Toremifene—Fatigue—Lisinopril—coronary artery disease	8.03e-05	0.000485	CcSEcCtD
Toremifene—Diphenhydramine—CYP2C19—coronary artery disease	8.02e-05	0.0257	CrCbGaD
Toremifene—Headache—Perindopril—coronary artery disease	8e-05	0.000483	CcSEcCtD
Toremifene—Pain—Lisinopril—coronary artery disease	7.97e-05	0.000481	CcSEcCtD
Toremifene—Constipation—Lisinopril—coronary artery disease	7.97e-05	0.000481	CcSEcCtD
Toremifene—Dizziness—Losartan—coronary artery disease	7.92e-05	0.000478	CcSEcCtD
Toremifene—Vomiting—Furosemide—coronary artery disease	7.9e-05	0.000477	CcSEcCtD
Toremifene—Rash—Furosemide—coronary artery disease	7.83e-05	0.000473	CcSEcCtD
Toremifene—Dermatitis—Furosemide—coronary artery disease	7.82e-05	0.000472	CcSEcCtD
Toremifene—Nausea—Captopril—coronary artery disease	7.82e-05	0.000472	CcSEcCtD
Toremifene—Tamoxifen—CYP2C19—coronary artery disease	7.81e-05	0.025	CrCbGaD
Toremifene—Headache—Furosemide—coronary artery disease	7.78e-05	0.00047	CcSEcCtD
Toremifene—Vomiting—Losartan—coronary artery disease	7.62e-05	0.00046	CcSEcCtD
Toremifene—Nausea—Perindopril—coronary artery disease	7.59e-05	0.000458	CcSEcCtD
Toremifene—Rash—Losartan—coronary artery disease	7.56e-05	0.000456	CcSEcCtD
Toremifene—Dermatitis—Losartan—coronary artery disease	7.55e-05	0.000456	CcSEcCtD
Toremifene—Headache—Losartan—coronary artery disease	7.51e-05	0.000453	CcSEcCtD
Toremifene—Nausea—Furosemide—coronary artery disease	7.38e-05	0.000445	CcSEcCtD
Toremifene—Asthenia—Ramipril—coronary artery disease	7.37e-05	0.000445	CcSEcCtD
Toremifene—Pruritus—Ramipril—coronary artery disease	7.27e-05	0.000439	CcSEcCtD
Toremifene—Asthenia—Timolol—coronary artery disease	7.21e-05	0.000435	CcSEcCtD
Toremifene—Nausea—Losartan—coronary artery disease	7.12e-05	0.00043	CcSEcCtD
Toremifene—Pruritus—Timolol—coronary artery disease	7.11e-05	0.000429	CcSEcCtD
Toremifene—Dizziness—Ramipril—coronary artery disease	6.79e-05	0.00041	CcSEcCtD
Toremifene—Asthenia—Lisinopril—coronary artery disease	6.69e-05	0.000404	CcSEcCtD
Toremifene—Dizziness—Timolol—coronary artery disease	6.64e-05	0.000401	CcSEcCtD
Toremifene—Pruritus—Lisinopril—coronary artery disease	6.59e-05	0.000398	CcSEcCtD
Toremifene—Vomiting—Ramipril—coronary artery disease	6.53e-05	0.000394	CcSEcCtD
Toremifene—Rash—Ramipril—coronary artery disease	6.48e-05	0.000391	CcSEcCtD
Toremifene—Dermatitis—Ramipril—coronary artery disease	6.47e-05	0.000391	CcSEcCtD
Toremifene—Headache—Ramipril—coronary artery disease	6.44e-05	0.000389	CcSEcCtD
Toremifene—Vomiting—Timolol—coronary artery disease	6.39e-05	0.000386	CcSEcCtD
Toremifene—Rash—Timolol—coronary artery disease	6.33e-05	0.000382	CcSEcCtD
Toremifene—Dermatitis—Timolol—coronary artery disease	6.33e-05	0.000382	CcSEcCtD
Toremifene—Headache—Timolol—coronary artery disease	6.29e-05	0.00038	CcSEcCtD
Toremifene—Dizziness—Lisinopril—coronary artery disease	6.16e-05	0.000372	CcSEcCtD
Toremifene—Nausea—Ramipril—coronary artery disease	6.1e-05	0.000368	CcSEcCtD
Toremifene—Nausea—Timolol—coronary artery disease	5.97e-05	0.00036	CcSEcCtD
Toremifene—Vomiting—Lisinopril—coronary artery disease	5.92e-05	0.000358	CcSEcCtD
Toremifene—Rash—Lisinopril—coronary artery disease	5.88e-05	0.000355	CcSEcCtD
Toremifene—Dermatitis—Lisinopril—coronary artery disease	5.87e-05	0.000354	CcSEcCtD
Toremifene—Headache—Lisinopril—coronary artery disease	5.84e-05	0.000352	CcSEcCtD
Toremifene—Nausea—Lisinopril—coronary artery disease	5.54e-05	0.000334	CcSEcCtD
Toremifene—CYP1A2—Metabolism—HADHA—coronary artery disease	7.41e-06	0.000103	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALDH2—coronary artery disease	7.4e-06	0.000103	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKR1B1—coronary artery disease	7.38e-06	0.000103	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HK2—coronary artery disease	7.38e-06	0.000103	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA1—coronary artery disease	7.33e-06	0.000102	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOB—coronary artery disease	7.28e-06	0.000101	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPA—coronary artery disease	7.24e-06	0.000101	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PLCB1—coronary artery disease	7.24e-06	0.000101	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LIPC—coronary artery disease	7.21e-06	0.0001	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HBA1—coronary artery disease	7.21e-06	0.0001	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2C19—coronary artery disease	7.21e-06	0.0001	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3C2A—coronary artery disease	7.21e-06	0.0001	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDN1—coronary artery disease	7.17e-06	9.97e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOC3—coronary artery disease	7.16e-06	9.97e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LDLR—coronary artery disease	7.12e-06	9.91e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL5—coronary artery disease	7.11e-06	9.89e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.1e-06	9.88e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC27A1—coronary artery disease	7.07e-06	9.84e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC9A1—coronary artery disease	7.04e-06	9.79e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTT1—coronary artery disease	7.04e-06	9.79e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SERPINE1—coronary artery disease	7.03e-06	9.79e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCA1—coronary artery disease	7.02e-06	9.77e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLCB3—coronary artery disease	7.02e-06	9.76e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CSF2—coronary artery disease	7e-06	9.74e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF1—coronary artery disease	7e-06	9.74e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CETP—coronary artery disease	6.95e-06	9.68e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCLC—coronary artery disease	6.95e-06	9.68e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LPL—coronary artery disease	6.95e-06	9.67e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA5—coronary artery disease	6.94e-06	9.66e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.94e-06	9.65e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LCAT—coronary artery disease	6.94e-06	9.65e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MEF2C—coronary artery disease	6.89e-06	9.59e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RPS6KB1—coronary artery disease	6.89e-06	9.59e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SDC1—coronary artery disease	6.88e-06	9.57e-05	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	6.83e-06	9.5e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—P4HB—coronary artery disease	6.81e-06	9.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA4—coronary artery disease	6.81e-06	9.47e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GGT1—coronary artery disease	6.8e-06	9.46e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GOT1—coronary artery disease	6.8e-06	9.46e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	6.75e-06	9.39e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ITGB3—coronary artery disease	6.71e-06	9.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	6.69e-06	9.3e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	6.61e-06	9.2e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.58e-06	9.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCLM—coronary artery disease	6.58e-06	9.15e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	6.53e-06	9.09e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PPP2CA—coronary artery disease	6.52e-06	9.08e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMA6—coronary artery disease	6.5e-06	9.04e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMB5—coronary artery disease	6.5e-06	9.04e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCD—coronary artery disease	6.41e-06	8.91e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.37e-06	8.86e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.37e-06	8.86e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CTGF—coronary artery disease	6.35e-06	8.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—VCAN—coronary artery disease	6.3e-06	8.77e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT2—coronary artery disease	6.29e-06	8.75e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMGCR—coronary artery disease	6.29e-06	8.75e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.27e-06	8.73e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR2A—coronary artery disease	6.27e-06	8.72e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—C3—coronary artery disease	6.26e-06	8.71e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDOA—coronary artery disease	6.25e-06	8.7e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HADH—coronary artery disease	6.18e-06	8.6e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ARNTL—coronary artery disease	6.18e-06	8.6e-05	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	6.17e-06	8.58e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—coronary artery disease	6.11e-06	8.5e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DCN—coronary artery disease	6.07e-06	8.45e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARGC1A—coronary artery disease	6.05e-06	8.42e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—coronary artery disease	6.02e-06	8.38e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—coronary artery disease	5.97e-06	8.31e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AGT—coronary artery disease	5.95e-06	8.28e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAT—coronary artery disease	5.94e-06	8.27e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDH2—coronary artery disease	5.91e-06	8.22e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX2—coronary artery disease	5.86e-06	8.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA2—coronary artery disease	5.86e-06	8.15e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.86e-06	8.15e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—coronary artery disease	5.83e-06	8.11e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—coronary artery disease	5.83e-06	8.11e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.79e-06	8.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HK1—coronary artery disease	5.79e-06	8.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX4—coronary artery disease	5.79e-06	8.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.79e-06	8.05e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLCB1—coronary artery disease	5.78e-06	8.05e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOB—coronary artery disease	5.77e-06	8.03e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOA1—coronary artery disease	5.76e-06	8.02e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.76e-06	8.01e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LIPC—coronary artery disease	5.75e-06	8.01e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	5.75e-06	8.01e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HBA1—coronary artery disease	5.75e-06	8.01e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2C19—coronary artery disease	5.75e-06	8.01e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HADHA—coronary artery disease	5.72e-06	7.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOC3—coronary artery disease	5.72e-06	7.96e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—coronary artery disease	5.71e-06	7.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LDLR—coronary artery disease	5.68e-06	7.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.68e-06	7.9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK14—coronary artery disease	5.67e-06	7.89e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.65e-06	7.87e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC9A1—coronary artery disease	5.62e-06	7.82e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—coronary artery disease	5.62e-06	7.82e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—coronary artery disease	5.61e-06	7.81e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCA1—coronary artery disease	5.61e-06	7.8e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPA—coronary artery disease	5.59e-06	7.78e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCLC—coronary artery disease	5.55e-06	7.73e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CETP—coronary artery disease	5.55e-06	7.73e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LPL—coronary artery disease	5.51e-06	7.66e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FN1—coronary artery disease	5.5e-06	7.65e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2—coronary artery disease	5.5e-06	7.65e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SDC1—coronary artery disease	5.49e-06	7.64e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6ST—coronary artery disease	5.47e-06	7.62e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFKBIA—coronary artery disease	5.43e-06	7.56e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT1—coronary artery disease	5.43e-06	7.55e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GGT1—coronary artery disease	5.43e-06	7.55e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.41e-06	7.53e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—coronary artery disease	5.37e-06	7.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA5—coronary artery disease	5.36e-06	7.46e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KIT—coronary artery disease	5.26e-06	7.32e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—P4HB—coronary artery disease	5.26e-06	7.31e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CD36—coronary artery disease	5.23e-06	7.28e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMA6—coronary artery disease	5.19e-06	7.22e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMB5—coronary artery disease	5.19e-06	7.22e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.18e-06	7.2e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPP2CA—coronary artery disease	5.17e-06	7.19e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.16e-06	7.18e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CTGF—coronary artery disease	5.07e-06	7.05e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GSK3B—coronary artery disease	5.05e-06	7.02e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMGCR—coronary artery disease	5.02e-06	6.99e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT2—coronary artery disease	5.02e-06	6.99e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—coronary artery disease	5.01e-06	6.97e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CREB1—coronary artery disease	5.01e-06	6.97e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—coronary artery disease	4.96e-06	6.9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—coronary artery disease	4.9e-06	6.82e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6R—coronary artery disease	4.88e-06	6.79e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—coronary artery disease	4.88e-06	6.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—VCAN—coronary artery disease	4.86e-06	6.77e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARGC1A—coronary artery disease	4.83e-06	6.72e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.83e-06	6.71e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—coronary artery disease	4.82e-06	6.7e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—coronary artery disease	4.81e-06	6.69e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAT—coronary artery disease	4.75e-06	6.6e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AGT—coronary artery disease	4.71e-06	6.56e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DCN—coronary artery disease	4.68e-06	6.52e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLCB1—coronary artery disease	4.62e-06	6.42e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—coronary artery disease	4.62e-06	6.42e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOB—coronary artery disease	4.61e-06	6.41e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—coronary artery disease	4.57e-06	6.36e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOA1—coronary artery disease	4.56e-06	6.35e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.56e-06	6.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.53e-06	6.3e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—coronary artery disease	4.48e-06	6.24e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCA1—coronary artery disease	4.48e-06	6.23e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LIPC—coronary artery disease	4.44e-06	6.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HBA1—coronary artery disease	4.44e-06	6.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.44e-06	6.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.44e-06	6.18e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF2—coronary artery disease	4.43e-06	6.16e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOC3—coronary artery disease	4.41e-06	6.14e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LPL—coronary artery disease	4.4e-06	6.12e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LDLR—coronary artery disease	4.39e-06	6.1e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.37e-06	6.08e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—coronary artery disease	4.37e-06	6.07e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.33e-06	6.03e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.33e-06	6.03e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT1—coronary artery disease	4.33e-06	6.03e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GGT1—coronary artery disease	4.33e-06	6.03e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—coronary artery disease	4.29e-06	5.97e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCLC—coronary artery disease	4.28e-06	5.96e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CETP—coronary artery disease	4.28e-06	5.96e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAK2—coronary artery disease	4.24e-06	5.9e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SDC1—coronary artery disease	4.24e-06	5.9e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CD36—coronary artery disease	4.18e-06	5.82e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPP2CA—coronary artery disease	4.13e-06	5.74e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—coronary artery disease	4.02e-06	5.6e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMA6—coronary artery disease	4e-06	5.57e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMB5—coronary artery disease	4e-06	5.57e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—coronary artery disease	3.97e-06	5.52e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—coronary artery disease	3.96e-06	5.51e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CTGF—coronary artery disease	3.91e-06	5.44e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—coronary artery disease	3.89e-06	5.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.88e-06	5.39e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT2—coronary artery disease	3.88e-06	5.39e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—coronary artery disease	3.87e-06	5.39e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	3.86e-06	5.37e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—coronary artery disease	3.84e-06	5.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAT—coronary artery disease	3.79e-06	5.27e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AGT—coronary artery disease	3.76e-06	5.24e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—coronary artery disease	3.71e-06	5.16e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—coronary artery disease	3.69e-06	5.13e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOB—coronary artery disease	3.68e-06	5.12e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA1—coronary artery disease	3.65e-06	5.07e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—coronary artery disease	3.62e-06	5.03e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—coronary artery disease	3.61e-06	5.02e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—coronary artery disease	3.58e-06	4.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.56e-06	4.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPL—coronary artery disease	3.51e-06	4.89e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—coronary artery disease	3.5e-06	4.87e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—coronary artery disease	3.46e-06	4.81e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.45e-06	4.81e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—coronary artery disease	3.43e-06	4.77e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GGT1—coronary artery disease	3.35e-06	4.65e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT1—coronary artery disease	3.35e-06	4.65e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CD36—coronary artery disease	3.34e-06	4.64e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.29e-06	4.58e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—coronary artery disease	3.21e-06	4.47e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—coronary artery disease	3.17e-06	4.41e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—coronary artery disease	3.16e-06	4.4e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—coronary artery disease	3.16e-06	4.4e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—coronary artery disease	3.15e-06	4.38e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—coronary artery disease	3.09e-06	4.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—coronary artery disease	3e-06	4.18e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AGT—coronary artery disease	3e-06	4.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.98e-06	4.14e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.96e-06	4.12e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—coronary artery disease	2.94e-06	4.1e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAT—coronary artery disease	2.92e-06	4.07e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA1—coronary artery disease	2.91e-06	4.05e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—coronary artery disease	2.89e-06	4.02e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—coronary artery disease	2.89e-06	4.02e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOB—coronary artery disease	2.84e-06	3.95e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK1—coronary artery disease	2.83e-06	3.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.79e-06	3.88e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—coronary artery disease	2.76e-06	3.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.76e-06	3.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPL—coronary artery disease	2.71e-06	3.77e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—coronary artery disease	2.64e-06	3.68e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CD36—coronary artery disease	2.58e-06	3.58e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—coronary artery disease	2.56e-06	3.57e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.54e-06	3.54e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—coronary artery disease	2.53e-06	3.52e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—coronary artery disease	2.53e-06	3.52e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—coronary artery disease	2.46e-06	3.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.44e-06	3.4e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AGT—coronary artery disease	2.32e-06	3.23e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—coronary artery disease	2.31e-06	3.21e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—coronary artery disease	2.27e-06	3.16e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA1—coronary artery disease	2.25e-06	3.12e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—coronary artery disease	2.21e-06	3.07e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—coronary artery disease	2.18e-06	3.03e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—coronary artery disease	2.02e-06	2.81e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—coronary artery disease	2.01e-06	2.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—coronary artery disease	1.98e-06	2.75e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—coronary artery disease	1.95e-06	2.72e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—coronary artery disease	1.95e-06	2.71e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—coronary artery disease	1.78e-06	2.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—coronary artery disease	1.7e-06	2.37e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—coronary artery disease	1.59e-06	2.21e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.56e-06	2.17e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.55e-06	2.16e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—coronary artery disease	1.27e-06	1.77e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.24e-06	1.73e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—coronary artery disease	1.01e-06	1.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—coronary artery disease	9.58e-07	1.33e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—coronary artery disease	7.82e-07	1.09e-05	CbGpPWpGaD
